Filing metadata

Accession number
0001209191-18-064161
Form type
Form 3
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Dec 27, 2018
Reporting period
Dec 17, 2018
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub